Tuesday, 3 December 2013

Cell Surface Markers Market is Expected to Reach USD 23.03 Billion Globally in 2019: Transparency Market Research

Transparency Market Research published new market report "Cell Surface Markers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global cell surface markers market was valued at USD 13.2 billion in 2012 and is expected to grow at a CAGR of 8.1% from 2013 to 2019, to reach an estimated value of USD 23.03 billion in 2019.


Cell surface markers are expressed on the surface of cells and function as identifiers of certain type of cells. The presence of cell markers also assists in the determination of cell type expression of specific receptors vital for biological response. Cell surface marker analysis is also essential in determination of experimental drug or ligand response. Rapid development in healthcare technology, growing preference for reduction of healthcare expenditure by lowering the cost of diagnosis, reduction in the risk of misdiagnosis, rapid and efficient decision making for therapies for specific diseases are some of the major factors which support the growing acceptance of cell surface marker analysis worldwide.

Browse full PDF with TOC: Cell Surface Markers Market

On the other hand, complexity of high-end flow cytometers and high cost of reagents, controls and analysis systems result into lowering the adoption of sophisticated cell marker analysis solutions, particularly in economically lagged countries. Increased market consolidation, simplification of analysis products, cost containment of such products and introduction of cheaper products in less developed markets are the major market strategies which are being adopted by the existing and emerging market players to sustain the cell surface markers market.

The global cell surface markers market can be categorized into instruments and reagents, kits and controls used for cell marker analysis. Flow cytometers and hematology analyzers are the prime cell marker analysis equipment used. Flow cytometry is the most prominently used tool for cell marker analysis. Availability of a wide range of flow cytometers and their efficacy in both research and drug discovery are the major factors driving the demand for flow cytometers. It is expected that the global market for flow cytometers will grow at a CAGR of more than 8% from 2013 to 2019 with a cumulative installed base of approximately over 85,000 units by 2019.

Disease diagnosis and identification and research and drug discovery are the two prime application areas of cell surface marker analysis. Cell markers analysis is essential in drug discovery and its use in R&D by pharmaceutical manufacturers and researchers widespread. Thus in terms of allocations, drug discovery and research segment is expected to dominate the global cell surface markers during the given period of forecast.

Geographically, North America is the dominant regional market for cell surface markers with almost half of the market share. Emerging countries of Asia-Pacific, Latin America and Middle-East are expected to undergo rapid market growth by 2019. Improvement in healthcare infrastructure and growing preference for safer and easier targeted therapies are the major factors which will fuel the market growth in these regions.

The cell surface markers market is highly fragmented and consists of many large and small players. The competition in this market is characterized by market consolidation activities, partnerships and intensive mergers and acquisitions. Some of the major companies in the cell surface markers market include Abbott Laboratories, Beckman Coulter, BD Biosciences, Bio-Rad, Seimens Healthcare, Nihon Kohden Corporation, Sysmex Corporation and Roche Diagnostics.

The global cell surface markers market is segmented as follows:

Cell Surface Markers Market, by Instruments and Reagents
  • Flow Cytometers
  • Hematology Analyzers
  • Reagents and Kits

Cell Surface Markers Market, by Applications
  • Disease Diagnosis and Identification
  • Research and Drug Discovery

Cell Surface Markers Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Wednesday, 27 November 2013

Medicine Education Publishing Market - Global Industry Size, Market Share, Trends, Analysis And Forecast 2012-2018

According to the latest market report published by Transparency Market Research "General Medicine Education Publishing Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012-2018", the global publishing market for general medicine education was worth USD 2.45 billion in 2012 and is expected to reach USD 3.6 billion in 2018, growing at a CAGR of 6.8% from 2012 to 2018. In the overall global market, North America is expected to continue its lead position in terms of revenue generation till 2018 with a share of 51.9% of the global market followed by Europe at 30.9%.

Browse the full report: http://www.transparencymarketresearch.com/general-medicine-education-publishing.html

Among the different market segments, custom content publishing segment is estimated to hold maximum share with 57% market share in the total general medicine market. The reason for its high share is the price of publishing custom content material, which is quite high as compared to any other publishing. This is followed by the market for online reference tools such as WebMD (Medscape), MDconsult, Micromedex among many others. Most popular online reference platforms have dedicated subscriptions, which have thus accounted for steady revenue generation. E-books and printed textbooks & reference books account for the third largest share in the general medicine education market.

The major drivers of the market include increase in online education, growth of e-books and need of primary healthcare. Primary healthcare is delivered by specialists in general medicine or internal medicine and are called Internists. The major factors restraining the market are the low adoption rate of online education in developing regions of the world, since a large fraction of population is not exposed to modern technology added to the decreasing number of students opting for medical specializations that brings a higher income.

The key players in the medical publishing market include Reed Elsevier, Wolters Kluwer, Thomson, Mc Graw-Hill, and Optum Health among others. Reed Elsevier is currently considered as overall market leader with popular contributions to books in internal medicine such as Davidson's Principles and Practice of medicine. A comprehensive assessment of key players and their strategies along with winning imperatives have been analyzed in this report by segmenting the market as below:


Electronic & online publishing market for general medicine education

  • Online Reference Tools
  • Mobile Applications
  • Electronic & Digital textbooks and reference books
  • Multimedia Content
  • Testing & Self-Assessmen
  • Hospital Training
  • Distance Learning


Print publishing market for general medicine education

  • Custom content publishing
  • Print textbooks and reference books
  • Testing & Self-Assessment
  • Hospital Training
  • Distance Learning


In addition a detailed cross sectional analysis of the above segments with respect to the following geographical markets has been performed:

  • North America
  • EuropeAsia
  • Rest of the World (RoW) 


Monday, 25 November 2013

Healthcare Cloud Computing Market- Global Industry Analysis, Size, Share, Trends and Forecast 2012 – 2018


According to a new market report published by Transparency Market Research "Cloud Computing Market In Healthcare Industry (IaaS, SaaS, PaaS, CIS, NCIS, PACS, EMR, RIS) – Global Industry Analysis, Size, Share, Trends and Forecast, 2012 – 2018" the global cloud computing market in the healthcare industry was valued at USD 1.82 billion in 2011 and is expected to reach USD 6.79 billion by 2018, growing at a CAGR of 21.3% from 2012 to 2018.

Browse full report with TOC: http://www.transparencymarketresearch.com/healthcare-cloud-computing.html

The report provides the market estimate and forecast in terms of revenue for the global cloud computing market in healthcare industry. A detailed analysis of the market trends, current scenarios and future trends from 2012 to 2018 is available in the report. The market is analyzed by using concepts such as market dynamics including drivers, restraints and opportunities along with their impact analysis and market attractiveness analysis. 

The market is segmented on the basis of cloud types into: Public, private and hybrid cloud. A detailed trend analysis of all the segments with market evaluation in terms of revenue generated with respect to the applications and geography is available in this report.

The market is also segmented on the basis of geography into: North America, Europe, Asia and rest of the world (RoW) regions. Geography wise, market evaluation is available in terms of revenue from 2012 to 2018.

A competitive analysis of the market players involved is also available in the report. Some of the major players of this market include: CareCloud, ClearDATA Networks, Merge Healthcare, Agfa Healthcare, IBM Corporation, Microsoft, Carestream Health, Oracle Corporation and others. Company overview, financial overview, business strategies, SWOT analysis, recent developments and product portfolio for each of the market players is also highlighted in the report.

The study presents a comprehensive assessment of the stakeholder strategies and their winning imperatives by segmenting the cloud computing market in healthcare industry as below:

Global cloud computing market in healthcare industry by service models
  • Infrastructure-as-a-Service (IaaS)
  • Platform-as-a-Service (PaaS)
  • Software-as-a-Service (SaaS)

Global cloud computing market in healthcare industry by pricing models
  • Spot pricing or subscription model
  • Pay-as-you-go model

Global cloud computing market in healthcare industry by end user applications
Clinical Information systems (CIS) cloud computing market
  • EMR
  • PACS
  • RIS
  • Others

Non-Clinical Information systems (NCIS) cloud computing market
  • RCM
  • Claims management
  • APB
  • Others

Global cloud computing market in healthcare industry by geography
  • North America
  • Europe
  • Asia
  • RoW

Blogs:
http://usamarketresearch.wordpress.com/
http://pharmaceuticalmarkets.wordpress.com

Friday, 22 November 2013

Global Peptide Therapeutics Market (Industry Analysis, Size, Share, Growth, Trends)- New Market Research Report Published by Transparency Market Research

The Peptide therapeutics is currently offering a new commercial potential to pharmaceuticals and biotechnology industry. To exploit this emerging market, large pharmaceutical and biotechnological firms are actively investing in development of newer peptides for various applications and are also opting for newer technologies for syntheses of these peptides. Cancer is the leading cause of death globally; according to the WHO (World Health Organization), around 12.7 million new cancer cases occurred in the year 2008. About 7 million people die from cancer every year and it is estimated that there will be more than 16 million new cancer cases every year by 2020. With rise in cancer patients and metabolic diseases like diabetes, there has been a push in growth for peptide molecules since chemotherapy, which is the major mode of treatment for cancer, is facing major challenges  due to its inability to deliver the correct amount of drug directly. In addition, it affects the normal cells in the body. 

Browse full Report with TOC: http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

Likewise, peptide application in various other treatments has opened a promising avenue for future growth of this market. New routes of peptide administration are being investigated; however the parenteral route continues to dominate this market and accounted for a share of almost 86% of the entire market. Similarly, the technology market is ruled by LPPS (long phase peptide syntheses) and is anticipated to decline owing to huge demand for solid phase peptide syntheses and hybrid syntheses.

This report analyzes the peptide therapeutics market by types of applications (cancer, metabolic, neurological diseases and others), route of administration, by types (innovative and generic), by API therapeutics market (in-house vs. CMO), by peptide therapeutics, and technology. Each of these markets is analyzed by studying the current and future market scenario, with estimation for the period 2010 – 2018 in terms of value in USD million.

The peptide therapeutics market is also segmented based on geography into North America, Europe, Asia and rest of the world (RoW) regions. The market for all these geographical regions is provided in the report in terms of revenue. The report provides complete analysis of the factors responsible for driving and restraining the global peptide therapeutics market. 

Competitive landscape is provided with market players profiled with attributes like company overview, financial overview, business strategies, product portfolio and recent developments. Market shares in 2011 for the key players and CMO players are provided and recommendations to accentuate market shares and ensure sustainability are provided in this report Key market players profiled in this report are Eli Lilly, Roche, Amylin, Novo-Nordisk, Ipsen and others. While CMOs major players profiled are Bachem, Lonza, Peptisyntha, Polypeptide group and others.

Peptide Therapeutics Market, by Applications
Cancer
Metabolic
Cardiovascular
Dermatology
Anti-Infection
Neurology
Gastro Intestinal
Renal 
Respiratory
Pain
Others

Peptide Therapeutics Market, by Route of Administration
Parenteral
Oral
Pulmonary
Mucosal
Others

Peptide Therapeutics Market, by Types
Innovative
Generics

Peptide Therapeutics Market, by API Peptide 
In-House
CMO (Contract Manufacturing Organization)

Peptide Therapeutics by Technology
Liquid Phase Peptide Synthesis (LPPS)
Solid Phase Peptide Synthesis (SPPS)
Hybrid 

Peptide Therapeutics Market, by Geography
North America
Europe
Asia
RoW

Blogs:
http://usamarketresearch.wordpress.com/
http://pharmaceuticalmarkets.wordpress.com/

Tuesday, 19 November 2013

Global mHealth Market is Expected to Reach USD 10.2 Billion Globally by 2018: Transparency Market Research

Transparency Market Research is Published new Market Report "MHealth Market - Global Mobile Health Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 – 2018” The growth in mHealth market is primarily driven by the increasing adoption of smartphones, rising incidence of chronic diseases and growing number of mHealth applications. Mobile based healthcare services access is becoming almost ubiquitous worldwide. mHealth applications are rapidly gaining popularity due to growth in number of innovative solutions.

Browse full reports with TOC: http://www.transparencymarketresearch.com/mobile-health-market.html

The global mHealth market is segmented by services into: monitoring services, diagnostic services, healthcare system strengthening services and other services. Mobile operators, device vendors, content players and healthcare providers are the various participants of the mHealth market. The market has also been segmented by geography into North America, Europe, Asia Pacific and Rest of the World regions. Market estimates and forecasts are made after critical analysis of various macro and micro economic factors which directly and indirectly affect the market growth. Inclusion of these factors has helped in accurate crunching of numbers and has extended the report purview. The report includes market size estimation and forecasts for the period of 2011 to 2018 for each of the mHealth segments.

The report will support the strategy development of players across the supply chain including device vendors, mobile operators, content developers and healthcare providers. The trends in the mHealth market will help healthcare service providers in tapping the untapped segments and address unmet needs. The competitive landscape section will especially help content developers and healthcare providers in strengthening their position in the market.

An in-depth research and market analysis will allow mobile application developers, marketing companies, healthcare providers, content developers, research and development agencies, network operators, and system integrators to make informed decisions about development, marketing, and growth strategies.

Thursday, 14 November 2013

Global Bisphenol A Market is Expected to Reach USD 18.8 Billion by 2019: Transparency Market Research

Transparency Market Research is Published new Market Report " Bisphenol A Market for Polycarbonates, Epoxy Resins and Other Applications - Global Industry Analysis, Size, Share, Growth and Forecast, 2013 - 2019" which observes that bisphenol A market was worth USD 13.1 billion and is expected to reach USD 18.8 billion by 2019, growing at a CAGR of 5.4% from 2012 to 2018. In terms of volume, BPA demand in 2012 was around 6.5 million tons in 2012 and is expected to grow at a CAGR of 4.6% from 2013 to 2019.

Browse the full report with complete TOC: http://www.transparencymarketresearch.com/bisphenol-a-market.html

Polycarbonates are derivates of Bisphenol A and are known for their lightweight, toughness, optical clarity resistance to heat, and electrical resistance. Number of good physical and chemical properties makes BPA material of choice for making a large number of commercial goods such as water bottles, sports equipment, electrical and electronic equipment, and drink and food containers among others. The rebound in automobile and electronic industries in North America and Europe, as well as rapid economic growth in Asia Pacific is expected to remain a major driving force for Bisphenol A market. Volatile raw material prices are expected to be a key challenge for market participants.

Polycarbonates and epoxy resins are the important derivatives of Bisphenol A. Polycarbonate was the most dominant application segment of Bisphenol A, both in terms of production and consumption, in 2012. Polycarbonate led the overall bisphenol A market and accounted for a market share of 72.5% in 2012. Owing to the strong demand from various end-use industries that use polycarbonates such as sport equipment, electronic equipment etc. it is expected to exhibit moderate CAGR of 4.8% from 2013 to 2019. Other key applications of bisphenol A include flame retardants, unsaturated polyester resins, and polyacrylate, polyetherimide and polysulfone resins, which collectively accounted for very small share of total volume consumed in 2012. 

Asia Pacific accounted for 53.5% of the total bisphenol market in 2012, followed by North America and Europe. Asia Pacific is also expected to be the fastest growing regional market in terms of bisphenol A consumption and production. This can be attributed to the growing economies in this region. Cheap availability of raw materials, land, skilled labor, and equipment has resulted in Asia Pacific emerging as a key destination for Bisphenol A manufacturers. The key industry participants include Bayer Material Science, SABIC Innovative Plastics, and Momentive Specialty Chemicals Inc., Dow Chemicals, Nan Ya plastics Plastics and Mitsui Chemicals., among others.

Bisphenol A Market: Application Segment Analysis
Polycarbonates
Epoxy resins
Others (Flame retardants, unsaturated polyester resin, polyacrylate, polyetherimide, polysulfone resins, etc.)

Bisphenol A Market: Regional Analysis
North America
Europe
Asia pacific
Rest of the world

Wednesday, 13 November 2013

Global Flue Gas Desulfurization (FGD) Market is Expected to Reach USD 22.18 billion in 2019: Transparency Market Research

Transparency Market Research is Published new Market Report "FGD Market for new FGD systems (Wet and Dry FGD systems), Reagents and Replacement Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2019" global FGD market was valued at USD 14.89 billion in 2012 and is expected to reach USD 22.18 billionby 2019, growing at a CAGR of 5.8% from 2013 to 2019.

Browse the full report with complete TOC: http://www.transparencymarketresearch.com/flue-gas-desulfurization-systems.html

Stringent environmental regulations along with rising concerns among different government organizations due to increase in the concentration of SO2 in the atmosphere is expected to boost the FGD market. Rising electricity demand and still major dependence on coal for electricity production is enhancing the demand for FGD systems that can help in reducing the harmful effects of coal combustion.

Major applications analyzed in this market include new FGD systems and reagents and replacement market. Reagents and replacement market holds a significant share in the FGD market. Worn out FGD components need to be replaced and considerable amount of reagents is consumed yearly for running FGD systems, that is contributing to the growth of this market. New FGD systems segmented into wet and dry FGD systems. Wet FGD systems was the major technology used for the installation of FGD systems in 2012 capturing over 84% of the market and areexpected to maintain dominance in the coming years. Dry FGD systems cost less as compared to wet FGD systems but have higher maintenance cost with respect to wet FGD systems and captures rest of the new FGD systems market.

Asia Pacific dominated the global FGD market, accounting for 54.38% of the overall market in 2012. China, Japan, India,Thailand and Indonesia are the key regional markets in Asia Pacific. These regions are expected to witness a surge in FGD demand owing to increase in electricity requirement that is enhancing the demand for coal fired power plants and thereby FGD market. North America FGD market is estimated to reach USD 4.05 billion by 2019 while Europe FGD market is expected to grow at a CAGR of 2.8% from 2013 to 2019. Some of the key market participants that deal in FGD include Alstom, Siemens Energy, Babcock & Wilcox, Hamon RC, Thermax, Ducon Technologies, Mitsubishi Heavy Industries (MHI), and Marsulex Environmental Technologies (MET). The report provides an overview of these companies followed by their financial revenue, business strategies, and recent developments.

This research analyzes and estimates the performance and market of FGD in the global scenario, providing detailed trend analysis of the market by geography and comprehensive analysis of companies that are dealing in FGD. The report presents a thorough assessment of the strategies followed by different stakeholders by segmenting the FGD market as below:

Flue Gas Desulfurization Market: Application Analysis
•  New Flue Gas Desulfurization Systems
•  Reagents and Replacement market

New Flue Gas Desulfurization Systems Market: Technology Analysis
•  Wet FGD systems
•  Dry FGD systems

Flue Gas Desulfurization Market: Regional Analysis
•  North America
•  Europe
•  Asia-Pacific
•  Rest of the World (Middle East, Africa and Brazil)